United Therapeutics (UTHR) Change in Inventory (2009 - 2026)

United Therapeutics has disclosed Change in Inventory across 18 years of filings, most recently posting $17.7 million for Q2 2026.

• In Q2 2026, Change in Inventory rose 139.19% year-over-year to $17.7 million; the TTM figure through Jun 2026 stood at $91.8 million (up 121.2% YoY), while the FY2025 annual figure was $52.6 million, up 12.15% from the prior year.
• Change in Inventory came in at $17.7 million for Q2 2026 at United Therapeutics, down from $40.1 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $40.1 million in Q1 2026 to a low of -$5.7 million in Q1 2022.
• Average Change in Inventory over 5 years is $10.2 million, with a median of $10.2 million recorded in 2024.
• The largest YoY upside for Change in Inventory was 13800.0% in 2022 against a maximum downside of 359.09% in 2022.
• Over 5 years, Change in Inventory stood at $13.9 million in 2022, then tumbled by 49.64% to $7.0 million in 2023, then surged by 65.71% to $11.6 million in 2024, then jumped by 42.24% to $16.5 million in 2025, then climbed by 7.27% to $17.7 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $17.7 million in Q2 2026, $40.1 million in Q1 2026, and $16.5 million in Q4 2025.